RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $119,000 | -44.1% | 6,078 | -38.1% | 0.01% | -57.1% |
| Q3 2020 | $213,000 | +2942.9% | 9,824 | +3230.2% | 0.01% | – |
| Q2 2020 | $7,000 | -30.0% | 295 | -54.9% | 0.00% | -100.0% |
| Q1 2020 | $10,000 | +25.0% | 654 | +81.2% | 0.00% | – |
| Q4 2019 | $8,000 | +300.0% | 361 | +375.0% | 0.00% | – |
| Q2 2019 | $2,000 | -87.5% | 76 | -87.0% | 0.00% | -100.0% |
| Q4 2018 | $16,000 | -15.8% | 583 | -12.5% | 0.00% | 0.0% |
| Q3 2018 | $19,000 | -99.7% | 666 | +223.3% | 0.00% | 0.0% |
| Q2 2018 | $6,440,000 | +107233.3% | 206 | -8.4% | 0.00% | 0.0% |
| Q4 2017 | $6,000 | – | 225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |